{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\", docket_id = \"FDA-2007-N-0314\" and posted_year = 2008 sorted by posted_date descending", "rows": [["FDA-2007-N-0314-0060", "FDA", "FDA-2007-N-0314", "Ozone Depleting Substances, Epinephrine; OMB Changes, Executive Order 12866 (E.O.) - Reference", "Supporting & Related Material", "REF-Reference (internal unless indicated)", "2008-11-24T05:00:00Z", 2008, 11, null, null, "2008-12-21T02:10:24Z", null, 0, 0, "09000064807be656"], ["FDA-2007-N-0314-0059", "FDA", "FDA-2007-N-0314", "Ref. 17- HHS 71 FR 3848 Notice; Annual Update of the HHS Poverty Guidelines - Background Material to the Notice of Final Rule [FDA-2007-N-0314-0044]", "Supporting & Related Material", "BKG-Background Material", "2008-11-19T05:00:00Z", 2008, 11, null, null, "2008-12-21T02:10:25Z", null, 0, 0, "09000064807afff4"], ["FDA-2007-N-0314-0045", "FDA", "FDA-2007-N-0314", "Ref. 1- National Center for Health Statistics - Background Material to the Notice of Final Rule [FDA-2007-N-0314-0044]", "Supporting & Related Material", "BKG-Background Material", "2008-11-19T05:00:00Z", 2008, 11, null, null, "2008-12-21T02:10:29Z", null, 0, 0, "09000064807afefa"], ["FDA-2007-N-0314-0053", "FDA", "FDA-2007-N-0314", "Ref. 11 -  US EPA Final Rule, 71FR58504 - Background Material to the Notice of Final Rule [FDA-2007-N-0314-0044]", "Supporting & Related Material", "BKG-Background Material", "2008-11-19T05:00:00Z", 2008, 11, null, null, "2008-12-21T02:10:26Z", null, 0, 0, "09000064807aff97"], ["FDA-2007-N-0314-0047", "FDA", "FDA-2007-N-0314", "Ref. 3 - Global Strategy for Asthma Management & Prevention, Global Initiative for Asthma - Background Material to the Notice of Final Rule [FDA-2007-N-0314-0044]", "Supporting & Related Material", "BKG-Background Material", "2008-11-19T05:00:00Z", 2008, 11, null, null, "2008-12-21T02:10:28Z", null, 0, 0, "09000064807aff2b"], ["FDA-2007-N-0314-0048", "FDA", "FDA-2007-N-0314", "Ref. 4 - United Nations Environmental Programme - Background Material to the Notice of Final Rule [FDA-2007-N-0314-0044]", "Supporting & Related Material", "BKG-Background Material", "2008-11-19T05:00:00Z", 2008, 11, null, null, "2008-12-21T02:10:28Z", null, 0, 0, "09000064807aff3d"], ["FDA-2007-N-0314-0052", "FDA", "FDA-2007-N-0314", "Ref. 10 - Analysis Completed by FDA Based on Retail Sales Data from ACNielson - Background Material to the Notice of Final Rule [FDA-2007-N-0314-0044]", "Supporting & Related Material", "BKG-Background Material", "2008-11-19T05:00:00Z", 2008, 11, null, null, "2008-12-21T02:10:27Z", null, 0, 0, "09000064807aff90"], ["FDA-2007-N-0314-0054", "FDA", "FDA-2007-N-0314", "Ref.12 - Rozek, R. P. and Bishko, E.R., Economics Issues Raised in the FDA's Proposed Rule - Background Material to the Notice of Final Rule [FDA-2007-N-0314-0044]", "Supporting & Related Material", "BKG-Background Material", "2008-11-19T05:00:00Z", 2008, 11, null, null, "2008-12-21T02:10:26Z", null, 0, 0, "09000064807affb3"], ["FDA-2007-N-0314-0046", "FDA", "FDA-2007-N-0314", "Ref. 2- Expert Panel Report 3: Guidelines for the Diagnosis & Management of Asthma - Background Material to the Notice of Final Rule [FDA-2007-N-0314-0044]", "Supporting & Related Material", "BKG-Background Material", "2008-11-19T05:00:00Z", 2008, 11, null, null, "2008-12-21T02:10:29Z", null, 0, 0, "09000064807aff10"], ["FDA-2007-N-0314-0051", "FDA", "FDA-2007-N-0314", "Ref. 7 - American Lung Association, Trends in Asthma Morbidity and Mortality - Background Material to the Notice of Final Rule [FDA-2007-N-0314-0044]", "Supporting & Related Material", "BKG-Background Material", "2008-11-19T05:00:00Z", 2008, 11, null, null, "2008-12-21T02:10:27Z", null, 0, 0, "09000064807aff62"], ["FDA-2007-N-0314-0056", "FDA", "FDA-2007-N-0314", "Ref. 14 - Gal, A., and N.R. Chari, Phase Out CFC Albuterol Production by Early 2007 - Background Material to the Notice of Final Rule [FDA-2007-N-0314-0044]", "Supporting & Related Material", "BKG-Background Material", "2008-11-19T05:00:00Z", 2008, 11, null, null, "2008-12-21T02:10:25Z", null, 0, 0, "09000064807affcf"], ["FDA-2007-N-0314-0057", "FDA", "FDA-2007-N-0314", "Ref. 15 - Berger, W. E. et al., The Utility of the Health Plan Employer Data & Information Set - Background Material to the Notice of Final Rule [FDA-2007-N-0314-0044]", "Supporting & Related Material", "BKG-Background Material", "2008-11-19T05:00:00Z", 2008, 11, null, null, "2008-12-21T02:10:25Z", null, 0, 0, "09000064807affdd"], ["FDA-2007-N-0314-0044", "FDA", "FDA-2007-N-0314", "Use of Ozone-Depleting Substances; Removal of Essential-Use Designation (Epinephrine) - Notice of Final Rule", "Rule", "NFR-Notice of Final Rule", "2008-11-19T05:00:00Z", 2008, 11, "2008-11-19T05:00:00Z", null, "2011-06-11T16:26:51Z", "E8-27436", 0, 0, "09000064807b155a"], ["FDA-2007-N-0314-0049", "FDA", "FDA-2007-N-0314", "Ref. 5 - EPA, The Benefits & Costs of the Clean Air Act - Background Material to the Notice of Final Rule [FDA-2007-N-0314-0044]", "Supporting & Related Material", "BKG-Background Material", "2008-11-19T05:00:00Z", 2008, 11, null, null, "2008-12-21T02:10:28Z", null, 0, 0, "09000064807aff4a"], ["FDA-2007-N-0314-0050", "FDA", "FDA-2007-N-0314", "Ref. 6 - National Center for Health Statistics (March 28, 2007) - Background Material to the Notice of Final Rule [FDA-2007-N-0314-0044]", "Supporting & Related Material", "BKG-Background Material", "2008-11-19T05:00:00Z", 2008, 11, null, null, "2008-12-21T02:10:27Z", null, 0, 0, "09000064807aff50"], ["FDA-2007-N-0314-0055", "FDA", "FDA-2007-N-0314", "Ref. 13 - Analysis Completed by FDA Based on Prescription Data Provided by IMS - Background Material to the Notice of Final Rule [FDA-2007-N-0314-0044]", "Supporting & Related Material", "BKG-Background Material", "2008-11-19T05:00:00Z", 2008, 11, null, null, "2008-12-21T02:10:26Z", null, 0, 0, "09000064807affc4"], ["FDA-2007-N-0314-0058", "FDA", "FDA-2007-N-0314", "Ref.16 - Centers for Medicare and Medicaid Services - Background Material to the Notice of Final Rule [FDA-2007-N-0314-0044]", "Supporting & Related Material", "BKG-Background Material", "2008-11-19T05:00:00Z", 2008, 11, null, null, "2008-12-21T02:10:25Z", null, 0, 0, "09000064807affeb"], ["FDA-2007-N-0314-0016", "FDA", "FDA-2007-N-0314", "Background Material - CDC - \"Early Release of Selected Estimates Based on Data From the 2005 National Health Interview Survey\"", "Supporting & Related Material", "BKG-Background Material", "2008-08-11T04:00:00Z", 2008, 8, null, null, "2008-08-11T17:10:28Z", null, 0, 0, "090000648042b724"], ["FDA-2007-N-0314-0027", "FDA", "FDA-2007-N-0314", "Background Material ' Medicaid At-a-GLance 2005 - A medicaid Information Source", "Supporting & Related Material", "BKG-Background Material", "2008-08-11T04:00:00Z", 2008, 8, null, null, "2008-08-11T18:24:35Z", null, 0, 0, "090000648042b746"], ["FDA-2007-N-0314-0029", "FDA", "FDA-2007-N-0314", "Background Material - Table of Contents to References for the Proposed Rule on Use of Ozone-Depleting Substances; Removal of Essential-Use Designation (Epinephrine)", "Supporting & Related Material", "BKG-Background Material", "2008-08-11T04:00:00Z", 2008, 8, null, null, "2008-08-11T18:24:37Z", null, 0, 0, "090000648042b748"], ["FDA-2007-N-0314-0028", "FDA", "FDA-2007-N-0314", "Background Material - FR - Annual Update of the HHS Poverty", "Supporting & Related Material", "BKG-Background Material", "2008-08-11T04:00:00Z", 2008, 8, null, null, "2008-08-11T18:24:36Z", null, 0, 0, "090000648042b747"], ["FDA-2007-N-0314-0023", "FDA", "FDA-2007-N-0314", "Background Material - Analysis Completed by FDA based on Retail Sales Data from Drug Stores and Supermarkets Provided by ACNielsen for the 52 Weeks Ending September 9, 2006.", "Supporting & Related Material", "BKG-Background Material", "2008-08-11T04:00:00Z", 2008, 8, null, null, "2008-08-11T18:24:31Z", null, 0, 0, "090000648042b742"], ["FDA-2007-N-0314-0020", "FDA", "FDA-2007-N-0314", "Background Material - \"National Healthcare Disparities Report\" - HHS", "Supporting & Related Material", "BKG-Background Material", "2008-08-11T04:00:00Z", 2008, 8, null, null, "2008-08-11T17:10:32Z", null, 0, 0, "090000648042b729"], ["FDA-2007-N-0314-0021", "FDA", "FDA-2007-N-0314", "Background Material - \"The Benefits and Costs of the Clean Air Act 1990 to 2010\" EPA", "Supporting & Related Material", "BKG-Background Material", "2008-08-11T04:00:00Z", 2008, 8, null, null, "2008-08-11T17:51:12Z", null, 0, 0, "090000648042b73d"], ["FDA-2007-N-0314-0018", "FDA", "FDA-2007-N-0314", "Background Material", "Supporting & Related Material", "BKG-Background Material", "2008-08-11T04:00:00Z", 2008, 8, null, null, "2008-08-11T17:10:30Z", null, 0, 0, "090000648042b726"], ["FDA-2007-N-0314-0025", "FDA", "FDA-2007-N-0314", "Background Material - ECONOMIC ISSUES RAISEDIN THE FDA\u2019S PROPOSED RULE ON Removing the Essential-Use Designation for Albuterol MDIs", "Supporting & Related Material", "BKG-Background Material", "2008-08-11T04:00:00Z", 2008, 8, null, null, "2008-08-11T18:24:33Z", null, 0, 0, "090000648042b744"], ["FDA-2007-N-0314-0024", "FDA", "FDA-2007-N-0314", "Background Material - FR Protection of Stratospheric Ozone...", "Supporting & Related Material", "BKG-Background Material", "2008-08-11T04:00:00Z", 2008, 8, null, null, "2008-08-11T18:24:32Z", null, 0, 0, "090000648042b743"], ["FDA-2007-N-0314-0015", "FDA", "FDA-2007-N-0314", "Background Material - \"Annual Demographic Survey\" - Bureau of Labor Statistics & Bureau of the Census", "Supporting & Related Material", "BKG-Background Material", "2008-08-11T04:00:00Z", 2008, 8, null, null, "2008-08-11T16:25:30Z", null, 0, 0, "090000648042b71e"], ["FDA-2007-N-0314-0022", "FDA", "FDA-2007-N-0314", "Background Material - CDC - Asthma episodes and current asthma", "Supporting & Related Material", "BKG-Background Material", "2008-08-11T04:00:00Z", 2008, 8, null, null, "2008-08-11T17:51:13Z", null, 0, 0, "090000648042b73e"], ["FDA-2007-N-0314-0026", "FDA", "FDA-2007-N-0314", "Background Material - Analysis Completed by FDA based on Prescription Data Provided by IMS Health, National Prescription Audit, 2004; IMS Health, IMS MIDAS (TM), Q1/2004\u2013Q2/2004", "Supporting & Related Material", "BKG-Background Material", "2008-08-11T04:00:00Z", 2008, 8, null, null, "2008-08-11T18:24:34Z", null, 0, 0, "090000648042b745"], ["FDA-2007-N-0314-0017", "FDA", "FDA-2007-N-0314", "Background Material - EXPERT PANEL REPORT 2 Guidelines for the Diagnosis and Management of Asthma\"", "Supporting & Related Material", "BKG-Background Material", "2008-08-11T04:00:00Z", 2008, 8, null, null, "2008-08-11T17:10:29Z", null, 0, 0, "090000648042b725"], ["FDA-2007-N-0314-0019", "FDA", "FDA-2007-N-0314", "Background Material - CDC/NCHS-\"Asthma Prevalence, Health Care Use and Mortality, 2002\"", "Supporting & Related Material", "BKG-Background Material", "2008-08-11T04:00:00Z", 2008, 8, null, null, "2008-08-11T17:10:31Z", null, 0, 0, "090000648042b728"], ["FDA-2007-N-0314-0013", "FDA", "FDA-2007-N-0314", "Background Material - Table of Contents to References for the Proposed Rule on Use of Ozone-Depleting Substances; Removal of Essential-Use Designation (Epinephrine)", "Supporting & Related Material", "BKG-Background Material", "2008-08-05T04:00:00Z", 2008, 8, null, null, "2008-08-05T14:02:31Z", null, 0, 0, "090000648042b715"], ["FDA-2007-N-0314-0014", "FDA", "FDA-2007-N-0314", "Background Material - Press Release:Alkermes Presents Positive Clinical Data for Inhaled Form of  Epinephrine", "Supporting & Related Material", "BKG-Background Material", "2008-08-05T04:00:00Z", 2008, 8, null, null, "2008-08-05T14:02:32Z", null, 0, 0, "090000648042b717"]], "truncated": false, "filtered_table_rows_count": 34, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 and \"posted_year\" = :p2 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2007-N-0314", "p2": "2008"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2007-N-0314&posted_year=2008", "results": [{"value": "FDA", "label": "FDA", "count": 34, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2007-N-0314&posted_year=2008", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2007-N-0314&posted_year=2008", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 33, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2007-N-0314&posted_year=2008&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Rule", "label": "Rule", "count": 1, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2007-N-0314&posted_year=2008&document_type=Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2007-N-0314&posted_year=2008", "results": [{"value": 2008, "label": 2008, "count": 34, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2007-N-0314", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2007-N-0314&posted_year=2008&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2007-N-0314&posted_year=2008&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2007-N-0314&posted_year=2008&_facet=posted_month"}, {"name": "last_modified", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2007-N-0314&posted_year=2008&_facet=last_modified"}, {"name": "posted_date", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2007-N-0314&posted_year=2008&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2007-N-0314&posted_year=2008&_facet_date=comment_start_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2007-N-0314&posted_year=2008&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 2022.8200160199776, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}